View Press Releases

Medidata Wins Award for Innovative Mobile App That Engages Patients in Clinical Trials

April 1, 2014

Medidata Entry Selected for Patient Engagement App Challenge Prize at 23rd Annual Partnerships in Clinical Trials Conference 

 

 
NEW YORK, N.Y. – April 1, 2014 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, won the Patient Engagement App Challenge (large organization category) at the 23rd Annual Partnerships in Clinical Trials Conference with a unique mobile app. The award recognizes Engage, Medidata’s app prototype, for its potential to positively transform the clinical trial experience for study participants at a time when capturing the voice of the patient is becoming increasingly important.

An easy-to-use, device-agnostic app that patients can access via their personal smartphones or other mobile devices, Engage is designed to educate, engage and empower study participants. It complements Medidata Patient Cloud™, a solution for patient-centric data capture and management offered as part of the industry-leading Medidata Clinical Cloud™, a comprehensive, seamless technology platform for the planning, setup and execution of clinical trials.                                     

“Medidata’s vision for transforming clinical trials is based on engaging patients in new and innovative ways,” said Glen de Vries, Medidata’s president. “By leveraging the smartphones, tablets and other mobile devices that study participants already have, we can provide continuous feedback as well as targeted messages to improve patient education, adherence, communications with their healthcare providers and outcomes.”

A team of Medidata engineers developed Engage during company-sponsored innovation time, a program Medidata put in place that allows employees to think creatively about solving problems and use technology in different ways. Engage creates new connections between patients, physicians and sponsors, but is built on top of Medidata’s industry-leading, cloud-based platform. 

“While at this stage Engage is only a prototype, it is an example of how Medidata is innovating and developing new ideas for our platform and solution roadmaps,” said Michelle Marlborough, Medidata’s vice president of product strategy. “We have so many talented engineers at Medidata, and we are committed to supporting them with the time and freedom to be creative. They have great ideas with tremendous potential to transform drug development and make a real difference in the lives of patients.”

Connect with Medidata: 

 

About Medidata  

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. 

 

###

 

Investor Contact: 

Hulus Alpay

Medidata Solutions

212.419.1025

halpay@mdsol.com

 

Media Contact: 

Gail Janowitz

Medidata Solutions

212.918.1792

gjanowitz@mdsol.com